- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The marketing authorisation for BTVPUR AlSap 1 has been withdrawn at the request of the marketing-authorisation holder.
BTVPUR AlSap 1 : EPAR - Summary for the public
English (EN) (216.82 KB - PDF)
български (BG) (273.86 KB - PDF)
español (ES) (219.81 KB - PDF)
čeština (CS) (279.88 KB - PDF)
dansk (DA) (215.41 KB - PDF)
Deutsch (DE) (241.24 KB - PDF)
eesti keel (ET) (244.85 KB - PDF)
ελληνικά (EL) (281.98 KB - PDF)
français (FR) (242.72 KB - PDF)
italiano (IT) (215.09 KB - PDF)
latviešu valoda (LV) (257.92 KB - PDF)
lietuvių kalba (LT) (242.99 KB - PDF)
magyar (HU) (257.59 KB - PDF)
Malti (MT) (287.39 KB - PDF)
Nederlands (NL) (215.61 KB - PDF)
polski (PL) (262.68 KB - PDF)
português (PT) (215.81 KB - PDF)
română (RO) (264.84 KB - PDF)
slovenčina (SK) (263.85 KB - PDF)
slovenščina (SL) (271.89 KB - PDF)
Suomi (FI) (214.4 KB - PDF)
svenska (SV) (215.45 KB - PDF)
Product information
BTVPUR AlSap 1 : EPAR - Product Information
English (EN) (905.71 KB - PDF)
български (BG) (1.59 MB - PDF)
español (ES) (959.08 KB - PDF)
čeština (CS) (1.31 MB - PDF)
dansk (DA) (976.46 KB - PDF)
Deutsch (DE) (1.05 MB - PDF)
eesti keel (ET) (962.08 KB - PDF)
ελληνικά (EL) (1.63 MB - PDF)
français (FR) (969.67 KB - PDF)
hrvatski (HR) (995.44 KB - PDF)
íslenska (IS) (1.21 MB - PDF)
italiano (IT) (409.73 KB - PDF)
latviešu valoda (LV) (588.19 KB - PDF)
lietuvių kalba (LT) (480.92 KB - PDF)
magyar (HU) (1.31 MB - PDF)
Malti (MT) (596.85 KB - PDF)
Nederlands (NL) (355.82 KB - PDF)
norsk (NO) (410.45 KB - PDF)
polski (PL) (595.12 KB - PDF)
português (PT) (421.48 KB - PDF)
română (RO) (479.93 KB - PDF)
slovenčina (SK) (582.8 KB - PDF)
slovenščina (SL) (563.67 KB - PDF)
Suomi (FI) (942.5 KB - PDF)
svenska (SV) (419.01 KB - PDF)
BTVPUR AlSap 1 : EPAR - All Authorised presentations
English (EN) (165.08 KB - PDF)
български (BG) (237.24 KB - PDF)
español (ES) (179.61 KB - PDF)
čeština (CS) (214.8 KB - PDF)
dansk (DA) (168.71 KB - PDF)
Deutsch (DE) (181.32 KB - PDF)
eesti keel (ET) (216.18 KB - PDF)
ελληνικά (EL) (224.9 KB - PDF)
français (FR) (168.45 KB - PDF)
hrvatski (HR) (203.36 KB - PDF)
íslenska (IS) (171.81 KB - PDF)
italiano (IT) (166.05 KB - PDF)
latviešu valoda (LV) (222.44 KB - PDF)
lietuvių kalba (LT) (215.2 KB - PDF)
magyar (HU) (208.44 KB - PDF)
Malti (MT) (226.37 KB - PDF)
Nederlands (NL) (169.29 KB - PDF)
norsk (NO) (166.89 KB - PDF)
polski (PL) (215.44 KB - PDF)
português (PT) (180.94 KB - PDF)
română (RO) (212.26 KB - PDF)
slovenčina (SK) (211.23 KB - PDF)
slovenščina (SL) (210.68 KB - PDF)
Suomi (FI) (168.59 KB - PDF)
svenska (SV) (168.12 KB - PDF)
Product details
- Name of medicine
- BTVPUR AlSap 1
- Active substance
- bluetongue-virus serotype-1 antigen
- International non-proprietary name (INN) or common name
- bluetongue-virus serotype-1 antigen
- Species
- Sheep
- Cattle
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QI04AA02
Pharmacotherapeutic group
ImmunologicalsTherapeutic indication
Active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotype 1.
Onset of immunity has been demonstrated three weeks after the primary vaccination course. The duration of immunity for cattle and sheep is one year after the primary vaccination course.
Authorisation details
- EMA product number
- EMEA/V/C/002230
- Marketing authorisation holder
- Merial
29 Avenue Tony Garnier
69007 Lyon
France - Marketing authorisation issued
- 17/12/2010
- Revision
- 4
Assessment history
BTVPUR AlSap 1 : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (202.88 KB - PDF)
BTVPUR AlSap 1-V-C-2230-S-02 : EPAR - Assessment Report - Annual re-assessment
English (EN) (406.33 KB - PDF)
BTVPUR AlSap 1 : EPAR - Scientific Discussion
English (EN) (509.9 KB - PDF)
CVMP summary of positive opinion for BTVPUR AlSap 1
English (EN) (224.61 KB - PDF)